Tarsus Pharmaceuticals, Inc. ( TARS) - Key Metrics
TARS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $4.01 | -$0.43 | $1.54 | $1.44 |
| 2026Q1 | $3.77 | -$0.16 | -$0.57 | -$0.71 |
| 2025Q4 | $3.54 | -$0.20 | $0.45 | $0.30 |
| 2025Q3 | $2.79 | -$0.30 | $0.43 | $0.38 |
| 2025Q2 | $2.42 | -$0.48 | -$0.69 | -$0.72 |
TARS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -36.59 |
| 2026Q1 | 0% | -109.61 |
| 2025Q4 | 0% | -102.35 |
| 2025Q3 | 0% | -49.53 |
| 2025Q2 | 0% | -21.10 |
TARS Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 2.30% | 0% |
| 2026Q1 | -1.01% | 0% |
| 2025Q4 | 0.37% | 0% |
| 2025Q3 | 0.65% | 0% |
| 2025Q2 | -1.77% | 0% |
TARS
Price: $69.20
52 week price:
Earnings Per Share: -1.08 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 37491
Market Capitalization: 3.1 billion